ZORYVE奶油有效缓解了皮肤各型的外皮皮肤炎症状,在第三阶段试验中证实是安全且可接受。 ZORYVE cream effectively alleviates atopic dermatitis symptoms across skin types, confirmed safe and tolerable in Phase 3 trials.

最近的一项研究表明,ZORYVE(Roflumilast)奶油0.15%有效缓解了各种皮肤类型的外皮皮肤炎症状,而不论其种族或族裔如何。 A recent study revealed that ZORYVE (Roflumilast) cream 0.15% effectively alleviates atopic dermatitis symptoms across various skin types, irrespective of race or ethnicity. 第3阶段试验,即第1和第2阶段,确认了所有参与者的治疗安全和可容忍性。 Phase 3 trials, INTEGUMENT-1 and -2, confirmed the treatment's safety and tolerability among all participants. 这些研究结果在2024年欧洲皮肤学和性病学学院大会上分享,由Arcutis生物治疗公司进行。 These findings were shared at the 2024 European Academy of Dermatology & Venereology Congress and conducted by Arcutis Biotherapeutics, Inc.